Trial Profile
A Single Blind, Double Dummy, Placebo Controlled, Randomized, 2 Period Crossover Study to Assess the Relative Bioavailability of a 120mg Tablet Compared to Two 60 mg SB-773812 Tablets in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs SB 773812 (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 19 Sep 2007 Status change
- 13 Aug 2007 New trial record.